Skip to main content


Texas Medical Center

Phone: 832-824-4822


1102 Bates Ave., Ste. 1570
Houston, TX 77030

Research Laboratory

Research Area

Lisa L. Wang, MD

Director, Bone Tumors Program
Clinical Leader, Musculoskeletal Tumor Clinic
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine fellowship Pediatric Hematology/Oncology 2001
Children's Hospital of Los Angeles residency Pediatrics 1996
University of North Carolina at Chapel Hill medical school Doctor of Medicine 1993
Washington University School of Medicine bachelors Bachelor of Arts 1988


Dr. Lisa Wang is Director of the Bone Tumor Program and the Clinical Leader of the Musculoskeletal Tumor Clinic at Texas Children's Cancer Center. Dr. Wang has a special interest in sarcomas, particularly bone sarcomas such as osteosarcoma and Ewing's sarcoma.

Dr. Wang is Director of the Bone Tumor Program at Texas Children's Cancer Center. The Bone Tumor Program brings together clinical and basic science researchers who are commonly investigating various aspects of osteosarcoma biology and treatment. The Bone Tumor Program promotes advanced research and clinical activities, which center around bone sarcomas, as part of the educational initiatives for hematology-oncology fellows and students.

Dr. Lisa Wang is also the Clinical Leader of the Musculoskeletal Tumor Clinic, an interdisciplinary clinic within the outpatient clinic at Texas Children's Cancer Center. The Musculoskeletal Tumor Clinic brings together a team of clinical specialists to decide on management plans for patients with bone tumors. The team includes an orthopedic surgeon, a pediatric oncologist, a pediatric nurse practitioner, a solid tumor fellow, and a social worker, among other caregivers.

She is certified by the American Board of Pediatrics in general pediatrics and pediatric hematology/oncology.


Organization Name Role
American Association for Cancer Research (AACR) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Human Genetics Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
Children's Oncology Group (COG) Member

Research Statement

Dr. Lisa Wang’s research interests focus on the molecular pathogenesis of osteosarcoma. She specifically focuses on the RECQL4 pathway and Rothmund-Thomson syndrome (RTS), a rare, inherited disorder that predisposes affected individuals to developing osteosarcoma.

Her research goals include:

understanding the molecular basis of Rothmund-Thomdon syndrome and related disorders by studying the mechanisms that predispose individuals to cancer development; defining the clinical phenotype and appropriate medical management of these patients; and understanding the role of RECQL4 pathways in the pathogenesis of osteosarcoma and skeletal development.



Latest Videos

The Future of Osteosarcoma and Other Pediatric Bone Tumors

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.